BioSpace News Archive

Biotech Bay

New 6-year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in Relapsing Multiple Sclerosis

Post-hoc analysis from 6 years of Phase III open-label extension studies showed Ocrevus treatment reduced the risk of needing a walking aid (EDSS≥6) by 49% in relapsing multiple sclerosis (RMS) patients compared with patients who switched from interferon beta-1a two years later

April 28, 2020
·
11 min read
Deals

Hansa Biopharma Interim Report Jan-Mar 2020. EMA Process on Track; an Opinion From the CHMP is Expected in the Second Quarter 2020

A formal adoption of outstanding questions, incl. definition of patients and design of the post approval study, expected at the CHMP April session

April 28, 2020
·
4 min read
Continued lack of PPE and testing, high sources of anxiety for physicians, new CMA poll says

The majority of physicians are feeling anxious about the pandemic and say that having more PPE and increasing testing would go a long way to help ease that anxiety, says a new poll by the Canadian Medical Association.

April 28, 2020
·
2 min read
BioMidwest

First Healthcare-Associated Infection Reduction Tied to Use of 90-Day Antimicrobial Coating, Study Indicates

Always-On™ surface coating demonstrates first correlation of sustained environmental bioburden reduction and 36% Healthcare-Associated Infection (HAI) declines

April 28, 2020
·
2 min read